pamidronate has been researched along with Chronic Illness in 27 studies
Excerpt | Relevance | Reference |
---|---|---|
"The objectives were to assess changes in radiological disease activity in children with chronic non-bacterial osteomyelitis (CNO) receiving pamidronate therapy and to test a modified radiological index for non-bacterial osteitis (mRINBO) in CNO." | 8.12 | Standardized reporting and quantification of whole-body MRI findings in children with chronic non-bacterial osteomyelitis treated with pamidronate. ( Andreasen, CM; Hauge, EM; Herlin, T; Jurik, AG; Klicman, RF, 2022) |
"To evaluate patient-reported effectiveness, safety and social influence of Pamidronate in the therapy of NSAIDs-refractory Chronic Recurrent Multifocal Osteomyelitis in children." | 8.12 | Patient-reported effectiveness and safety of Pamidronate in NSAIDs-refractory chronic recurrent multifocal osteomyelitis in children. ( Juszczak, B; Sułko, J, 2022) |
"Pamidronate use in a CCI population is associated with reduced mortality, lower hypoglycemia rates, improved albumin, and stable renal function." | 7.83 | INTRAVENOUS PAMIDRONATE IS ASSOCIATED WITH REDUCED MORTALITY IN PATIENTS WITH CHRONIC CRITICAL ILLNESS. ( Casey, MF; Godbold, JH; Mechanick, JI; Moshier, EL; Rho, L; Schulman, RC; Zaidi, M, 2016) |
"There are only a few studies that address the frequency and type of spinal involvement in patients with chronic recurrent multifocal osteomyelitis (CRMO) as well as the outcome of these patients treated with pamidronate (PAM)." | 7.76 | Spinal involvement in chronic recurrent multifocal osteomyelitis (CRMO) in childhood and effect of pamidronate. ( Dannecker, GE; Hospach, T; Langendoerfer, M; Maier, J; von Kalle, T, 2010) |
"We report a juvenile case of diffuse sclerosing osteomyelitis of the mandible that showed a favorable response to pamidronate, a bisphosphonate derivative." | 7.74 | Remarkable response of juvenile diffuse sclerosing osteomyelitis of mandible to pamidronate. ( Ishikawa, M; Kitagawa, Y; Nomura, K; Notani, K; Satoh, C; Yamazaki, Y, 2007) |
"Osteoporosis is a major complication of chronic cholestatic liver disease (CCLD)." | 5.38 | Pamidronate for the treatment of osteoporosis secondary to chronic cholestatic liver disease in Wistar rats. ( de Paula, FJ; Defino, HL; Facincani, I; Jorgetti, V; Mattar, R; Pereira, FA; Ramalho, LN; Volpon, JB, 2012) |
"The objectives were to assess changes in radiological disease activity in children with chronic non-bacterial osteomyelitis (CNO) receiving pamidronate therapy and to test a modified radiological index for non-bacterial osteitis (mRINBO) in CNO." | 4.12 | Standardized reporting and quantification of whole-body MRI findings in children with chronic non-bacterial osteomyelitis treated with pamidronate. ( Andreasen, CM; Hauge, EM; Herlin, T; Jurik, AG; Klicman, RF, 2022) |
"To evaluate patient-reported effectiveness, safety and social influence of Pamidronate in the therapy of NSAIDs-refractory Chronic Recurrent Multifocal Osteomyelitis in children." | 4.12 | Patient-reported effectiveness and safety of Pamidronate in NSAIDs-refractory chronic recurrent multifocal osteomyelitis in children. ( Juszczak, B; Sułko, J, 2022) |
"Pamidronate use in a CCI population is associated with reduced mortality, lower hypoglycemia rates, improved albumin, and stable renal function." | 3.83 | INTRAVENOUS PAMIDRONATE IS ASSOCIATED WITH REDUCED MORTALITY IN PATIENTS WITH CHRONIC CRITICAL ILLNESS. ( Casey, MF; Godbold, JH; Mechanick, JI; Moshier, EL; Rho, L; Schulman, RC; Zaidi, M, 2016) |
"There are only a few studies that address the frequency and type of spinal involvement in patients with chronic recurrent multifocal osteomyelitis (CRMO) as well as the outcome of these patients treated with pamidronate (PAM)." | 3.76 | Spinal involvement in chronic recurrent multifocal osteomyelitis (CRMO) in childhood and effect of pamidronate. ( Dannecker, GE; Hospach, T; Langendoerfer, M; Maier, J; von Kalle, T, 2010) |
"We report a juvenile case of diffuse sclerosing osteomyelitis of the mandible that showed a favorable response to pamidronate, a bisphosphonate derivative." | 3.74 | Remarkable response of juvenile diffuse sclerosing osteomyelitis of mandible to pamidronate. ( Ishikawa, M; Kitagawa, Y; Nomura, K; Notani, K; Satoh, C; Yamazaki, Y, 2007) |
"Pamidronate appears to be an effective treatment in children with CNO unresponsive to NSAIDs." | 1.40 | Efficacy of pamidronate therapy in children with chronic non-bacterial osteitis: disease activity assessment by whole body magnetic resonance imaging. ( Finn, A; Ramanan, AV; Roderick, M; Shah, R, 2014) |
"Osteoporosis is a major complication of chronic cholestatic liver disease (CCLD)." | 1.38 | Pamidronate for the treatment of osteoporosis secondary to chronic cholestatic liver disease in Wistar rats. ( de Paula, FJ; Defino, HL; Facincani, I; Jorgetti, V; Mattar, R; Pereira, FA; Ramalho, LN; Volpon, JB, 2012) |
"Five patients with CRMO, all of whom had ongoing pain and loss of function despite conventional treatment with non-steroidal anti-inflammatory agents, were treated with pamidronate (1 mg/kg/dose with a dosing frequency of 2 to 4 monthly for a total treatment duration of 12 to 42 months)." | 1.35 | Bisphosphonate treatment in chronic recurrent multifocal osteomyelitis. ( Allen, RC; Simm, PJ; Zacharin, MR, 2008) |
"A strategy that blocks localized bone resorption may prevent the progression of the disease." | 1.31 | Inhibition of cholesteatomatous bone resorption with pamidronate disodium. ( Chung, JW; Kim, HJ; Lee, SH; Park, MH; Yoon, TH, 2001) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (11.11) | 18.2507 |
2000's | 11 (40.74) | 29.6817 |
2010's | 7 (25.93) | 24.3611 |
2020's | 6 (22.22) | 2.80 |
Authors | Studies |
---|---|
Abdou, WM | 1 |
Ganoub, NA | 1 |
Geronikaki, A | 1 |
Sabry, E | 1 |
Andreasen, CM | 1 |
Klicman, RF | 1 |
Herlin, T | 1 |
Hauge, EM | 1 |
Jurik, AG | 1 |
Fraleigh, R | 1 |
Wei, XC | 1 |
Yu, W | 1 |
Miettunen, PM | 1 |
Stojkic, I | 1 |
Rubin, E | 1 |
Lee, J | 1 |
Lee, ASE | 1 |
Ogbu, EA | 1 |
Kaneko, S | 1 |
Shimizu, M | 1 |
Inoue, N | 1 |
Mizuta, M | 1 |
Yachie, A | 1 |
Bhat, CS | 1 |
Chopra, M | 1 |
Andronikou, S | 1 |
Paul, S | 1 |
Wener-Fligner, Z | 1 |
Merkoulovitch, A | 1 |
Holjar-Erlic, I | 1 |
Menegotto, F | 1 |
Simpson, E | 1 |
Grier, D | 1 |
Ramanan, AV | 2 |
Juszczak, B | 1 |
Sułko, J | 1 |
Handly, B | 1 |
Moore, M | 1 |
Creutzberg, G | 1 |
Groh, B | 1 |
Mosher, T | 1 |
Roderick, M | 1 |
Shah, R | 1 |
Finn, A | 1 |
Schulman, RC | 1 |
Moshier, EL | 1 |
Rho, L | 1 |
Casey, MF | 1 |
Godbold, JH | 1 |
Zaidi, M | 1 |
Mechanick, JI | 2 |
Alons, K | 1 |
Kuijpers, SC | 1 |
de Jong, E | 1 |
van Merkesteyn, JP | 1 |
Hospach, T | 1 |
Langendoerfer, M | 1 |
von Kalle, T | 1 |
Maier, J | 1 |
Dannecker, GE | 1 |
Scoletta, M | 1 |
Arduino, PG | 1 |
Dalmasso, P | 1 |
Broccoletti, R | 1 |
Mozzati, M | 1 |
Conejo-Fernández, A | 1 |
Núñez Cuadros, E | 1 |
Jiménez Hinojosa, JM | 1 |
Urda Cardona, AL | 1 |
Pereira, FA | 1 |
Mattar, R | 1 |
Facincani, I | 1 |
Defino, HL | 1 |
Ramalho, LN | 1 |
Jorgetti, V | 1 |
Volpon, JB | 1 |
de Paula, FJ | 1 |
Pappagallo, M | 1 |
Breuer, B | 1 |
Schneider, A | 1 |
Sperber, K | 1 |
Tokumoto, T | 1 |
Tanabe, K | 1 |
Toma, H | 1 |
Akiba, T | 1 |
Duque, G | 1 |
Segal, R | 1 |
Wise, F | 1 |
Bianco, J | 1 |
Yamazaki, Y | 1 |
Satoh, C | 1 |
Ishikawa, M | 1 |
Notani, K | 1 |
Nomura, K | 1 |
Kitagawa, Y | 1 |
Compeyrot-Lacassagne, S | 1 |
Rosenberg, AM | 1 |
Babyn, P | 1 |
Laxer, RM | 1 |
Simm, PJ | 1 |
Allen, RC | 1 |
Zacharin, MR | 1 |
Sinha, RN | 1 |
Fraser, WD | 1 |
Casson, IF | 1 |
Devogelaer, JP | 1 |
Nagant de Deuxchaisnes, C | 1 |
Nierman, DM | 1 |
Yoon, TH | 1 |
Lee, SH | 1 |
Park, MH | 1 |
Chung, JW | 1 |
Kim, HJ | 1 |
Coinde, E | 1 |
David, L | 1 |
Cottalorda, J | 1 |
Allard, D | 1 |
Bost, M | 1 |
Lucht, F | 1 |
Stéphan, JL | 1 |
Spindler, A | 1 |
Berman, A | 1 |
Mautalen, C | 1 |
Ubios, J | 1 |
Santini, AE | 1 |
2 reviews available for pamidronate and Chronic Illness
Article | Year |
---|---|
Chronic recurrent multifocal osteomyelitis with myositis: A case report and review of the literature.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Bone Density Conservation Agents; Child; Chronic Disease; C | 2020 |
[Treatment of bone disease in chronic kidney disease and in renal transplant recipients under K/DOQI clinical practice guidelines].
Topics: Bone Density; Bone Diseases, Metabolic; Calcitonin; Chronic Disease; Diphosphonates; Epoxy Compounds | 2004 |
25 other studies available for pamidronate and Chronic Illness
Article | Year |
---|---|
Synthesis, properties, and perspectives of gem-diphosphono substituted-thiazoles.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Bone Density Conservation Agents; Bone Resorption; | 2008 |
Standardized reporting and quantification of whole-body MRI findings in children with chronic non-bacterial osteomyelitis treated with pamidronate.
Topics: Child; Chronic Disease; Female; Humans; Magnetic Resonance Imaging; Male; Osteitis; Osteomyelitis; P | 2022 |
Chronic recurrent multifocal osteomyelitis with a comprehensive approach to differential diagnosis of paediatric skull pain.
Topics: Child; Chronic Disease; Diagnosis, Differential; Female; Humans; Magnetic Resonance Imaging; Osteiti | 2023 |
An unusual presentation of chronic recurrent multifocal osteomyelitis involving bones of the skull.
Topics: Adolescent; Child; Chronic Disease; Diagnostic Imaging; Humans; Male; Osteomyelitis; Pamidronate; Re | 2023 |
Artificial intelligence for interpretation of segments of whole body MRI in CNO: pilot study comparing radiologists versus machine learning algorithm.
Topics: Adolescent; Artificial Intelligence; Bone Density Conservation Agents; Chronic Disease; Disease Prog | 2020 |
Patient-reported effectiveness and safety of Pamidronate in NSAIDs-refractory chronic recurrent multifocal osteomyelitis in children.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Child; Chronic Disease; Drug-Related Side Effects and Adver | 2022 |
Bisphosphonate therapy for chronic recurrent multifocal osteomyelitis.
Topics: Adolescent; Bone Density Conservation Agents; Chronic Disease; Diphosphonates; Humans; Male; Osteomy | 2013 |
Efficacy of pamidronate therapy in children with chronic non-bacterial osteitis: disease activity assessment by whole body magnetic resonance imaging.
Topics: Adolescent; Anti-Inflammatory Agents; Child; Child, Preschool; Chronic Disease; Diphosphonates; Dise | 2014 |
INTRAVENOUS PAMIDRONATE IS ASSOCIATED WITH REDUCED MORTALITY IN PATIENTS WITH CHRONIC CRITICAL ILLNESS.
Topics: Adult; Aged; Aged, 80 and over; Bone Density Conservation Agents; Bone Resorption; Chronic Disease; | 2016 |
Treating low- and medium-potency bisphosphonate-related osteonecrosis of the jaws with a protocol for the treatment of chronic suppurative osteomyelitis: report of 7 cases.
Topics: Administration, Oral; Adult; Aged; Anti-Bacterial Agents; Bone Density Conservation Agents; Chronic | 2009 |
Spinal involvement in chronic recurrent multifocal osteomyelitis (CRMO) in childhood and effect of pamidronate.
Topics: Adolescent; Back Pain; Bone Density Conservation Agents; Child; Chronic Disease; Diphosphonates; Fem | 2010 |
Treatment outcomes in patients with bisphosphonate-related osteonecrosis of the jaws: a prospective study.
Topics: Aged; Alcohol Drinking; Alendronate; Anti-Bacterial Agents; Bone Density Conservation Agents; Chroni | 2010 |
[Pamidronate: a therapeutic alternative in chronic recurrent mutifocal osteomyelitis].
Topics: Child; Chronic Disease; Diphosphonates; Female; Humans; Osteomyelitis; Pamidronate; Recurrence | 2011 |
Pamidronate for the treatment of osteoporosis secondary to chronic cholestatic liver disease in Wistar rats.
Topics: Animals; Bone Density; Bone Density Conservation Agents; Cholestasis, Intrahepatic; Chronic Disease; | 2012 |
Treatment of chronic mechanical spinal pain with intravenous pamidronate: a review of medical records.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Back Pain; Chronic Disease; Diphosphonates | 2003 |
Chronic hypercalcemia as a reversible cause of cognitive impairment: improvement after a single administration of pamidronate.
Topics: Aged; Chronic Disease; Cognition Disorders; Diphosphonates; Female; Humans; Hypercalcemia; Hyperpara | 2005 |
Remarkable response of juvenile diffuse sclerosing osteomyelitis of mandible to pamidronate.
Topics: Bone Density Conservation Agents; Child; Chronic Disease; Diphosphonates; Humans; Male; Mandibular D | 2007 |
Pamidronate treatment of chronic noninfectious inflammatory lesions of the mandible in children.
Topics: Anti-Inflammatory Agents; Child; Child, Preschool; Chronic Disease; Diphosphonates; Female; Humans; | 2007 |
Bisphosphonate treatment in chronic recurrent multifocal osteomyelitis.
Topics: Adolescent; Child; Chronic Disease; Diphosphonates; Female; Humans; Male; Osteomyelitis; Pamidronate | 2008 |
Long-term management of hypercalcaemia in chronically active sarcoidosis.
Topics: Adult; Chronic Disease; Diphosphonates; Drug Therapy, Combination; Fatal Outcome; Female; Humans; Hy | 1997 |
Use of pamidronate in chronic and acute bone loss conditions.
Topics: Acute Disease; Bone Density; Bone Resorption; Chronic Disease; Diphosphonates; Female; Humans; Male; | 1997 |
Biochemical response to treatment of bone hyperresorption in chronically critically ill patients.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Biomarkers; Calcitriol; Calcium; Calcium C | 2000 |
Inhibition of cholesteatomatous bone resorption with pamidronate disodium.
Topics: Animals; Animals, Newborn; Anti-Inflammatory Agents; Bone Resorption; Calcium; Cholesteatoma, Middle | 2001 |
[Chronic recurrent multifocal osteomyelitis in children: report of 17 cases].
Topics: Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Biopsy; Bone and Bones; Child; Child, Pr | 2001 |
Chronic idiopathic hyperphosphatasia. Report of a case treated with pamidronate and a review of the literature.
Topics: Adult; Alkaline Phosphatase; Bone and Bones; Chronic Disease; Diphosphonates; Female; Humans; Hydrox | 1992 |